Transfection Optimization for Expression of the Recombinant Monoclonal Antibody against Plasmodium falciparum Lactate Dehydrogenase in Mammalian Cells

Authors

  • Panadda Dhepakson Medical Life Sciences Institute, Department of Medical Sciences
  • Apichai Prachasuphap Medical Life Sciences Institute, Department of Medical Sciences
  • Duangrat Jullaksorn Medical Life Sciences Institute, Department of Medical Sciences
  • Anicha Luengchaichaweng Medical Life Sciences Institute, Department of Medical Sciences
  • Sakulrat Soonthornchattrawat Medical Life Sciences Institute, Department of Medical Sciences
  • Porntip Chaiya Medical Life Sciences Institute, Department of Medical Sciences

Keywords:

Recombinant Plasmodium falciparun monoclonal antibody, 293F cells, transfection, Plasmodium falciparum lactate dehydrogenase

Abstract

       Recombinant plasmid pcDNA-pLDHAbHCγLCκ/C10 containing immunoglobulin gene encoding monoclonal antibody against lactate dehydrogenase enzyme of Plasmodium falciparum (pLDH) has been developed in our previous study. This study was aimed to optimize the condition of transfection reagent for experssion of thee crombinant monoclonal antibody against pLDH in 293F cs.e ll By optimizing transfection condition for a commercial pEGFP-N1 plasmid to transfection reagent, the optimal ratiowas at 1 μg:1.2 μl in 293F cells. By this ratio, the plasmid pcDNA-pLDHAbHCγLCκ/C10 was also transfected into 293F cells to express the recombinant monoclonal antibody and maximal level was found in culture supernatant at day 4 as determined by ELISA. The recombinant monoclonal antibody protein pattern was similar to that of the mouse monoclonal antibody against pLDH as analyzed by SDS-PAGE and Western blotting. Furthermore, this monoclonal antibody could react specifically to pLDH antigen in P. falciparum infected cells by IFA. Thus, the recombinant monoclonal antibody had potential in development for P. faciparum malarial diagnosis

References

Saleem M, Kamal M. Monoclonal antibodies in clinical diagnosis: A brief review application. Afr J Biotechnol 2008; 7(8): 923-5.

Drewe E, Powell RJ. Clinically useful monoclonal antibodies in treatment. J Clin Pathol 2002; 55(2): 81-85.

Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-7.

Pandey S. Hybridoma technology for production of monoclonal antibodies. Int J Pharm Sci Rev Res 2010; 1(2): 88-94.

Hybridoma technology. [online].2015; [cited 2015 Jul 7]; [1 screen]. Available from: URL: https://en.wikipedia.org/wiki/Hybridoma_technology#Method.

Marx U, Embleton MJ, Fischer R, Gruber FP, Hansson U, Heuer J, et al. Monoclonal antibody production: The report and recommendations of ECVAM Workshop 23. ATLA 1997; 25(2): 121-37.

National Research Council (US) Committee on Methods of Producing Monoclonal Antibodies. Monoclonal antibody production [online]. 1999; [cited 2015 Jun 22]. Available from: URL: https://www.ncbi.nlm.nih.gov/books/NBK100192.

Castillo FJ, Mullen LJ, Grant BC, Deleon J, Thrift JC, Chang LW, et al. Hydridoma stability. Dev Biol Stand 1994; 83: 55-64.

Skerra A, Plückthun A. Assembly a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988; 240(4855): 1038-41.

Ho M, Nagata S, Pastan I. Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. PNAS 2006; 103(25): 9637-42.

Galeffi P, Lombardi A, Pietraforte I, Novelli F, Donato MD, Sperandei M, et al. Functional expression of a single-chain antibody to Erb-2 in plants and cell-free systems. J Transl Med 2006; 4: 39.

Choo ABH, Dunn RD, Broady KW, Raison RL. Soluble expression of a functional recombinant cytolytic immunotoxin in insect cells. Protein Expr Purif 2002; 24(3): 338-47.

Zhang RY, Shen WD. Monoclonal antibody expression in mammalian cells. Methods Mol Biol 2012; 907: 341-58.

Durocher Y, Perret S, Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res 2002; 30: E9.

Thomas P, Smart TG. HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods 2005; 51: 187-200.

CLONTECH Laboatories, Inc. PEGFP-N1 vector information. [online]. 1999; [cited 2015 Jul 27]; [3 screens]. Available from: URL: https://shigen.nig.ac.jp/medaka/download/strain/pEGFP-N1.pdf.

Inouye S, Tsuji FI. Aequorea green fluorescence protein. Expression of the gene and fluorescence characteristics of the recombinant protein. FEBS Lett 1994; 341: 277-80.

Prasher DC, Eckenrode VK, Ward WW, Prendergast FG, Cormier MJ. Primary structure of the Aequorea victoria green-fluorescent protein. Gene 1992; 111: 229-33.

Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001; Appendix 3: Appendix 3B.

Markler MT, Hinrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg 1993; 48(2); 205-10.

Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC. Green fluorescence protein as a marker for gene expression. Science 1994; 263: 802-5.

Khodthong C, Ismaili I, Juckem L. The Impact of transfection mediated toxicity-gene expression and cytotoxicity analysis of transfection reagents. [online]. 2012; [2015 Jun 20]; [10 screens]. Available from: URL: https://www.mirusbio.com/assets/misc_technical_documents/the_impact_of_transfection_mediated_toxicity.pdf.

Backliwal G, Hildinger M, Chenuet S, Wulhfard S, De Jesus M, Wurm FM. Rational vector design and multi-pathway modulation of HEK 293E cells yield recombinant antibody titers exceeding 1 g/l by transient transfection under serum-free conditions. Nucleic Acids Res 2008; 36(15): e96.

Kim TK, Eberwine JH. Mammalian cell transfection: the present and the future. Anal Bioanal Chem 2010; 397(8): 3173-8.

Schroeder HW, Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol 2010; 125(202): S41-52.

Downloads

Published

30-12-2016

How to Cite

1.
Dhepakson P, Prachasuphap A, Jullaksorn D, Luengchaichaweng A, Soonthornchattrawat S, Chaiya P. Transfection Optimization for Expression of the Recombinant Monoclonal Antibody against Plasmodium falciparum Lactate Dehydrogenase in Mammalian Cells. ว กรมวิทย พ [internet]. 2016 Dec. 30 [cited 2025 Dec. 29];58(4):257-69. available from: https://he02.tci-thaijo.org/index.php/dmsc/article/view/241394

Issue

Section

Original Articles